TGTX ▼ -1.5% - TG Therapeutics, Inc.
$TGTX - TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026
23-OCT-2026 10:57 AM ET
Share this post
More filings for $TGTX
TGTX ▲ +3.7% - TG Therapeutics, Inc.Nov 9, 2026TGTX ▲ +5.4% - TG Therapeutics, Inc.Nov 9, 2026TGTX ▲ +0.3% - TG Therapeutics, Inc.Nov 2, 2026TGTX - TG Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026TGTX ▼ -1.5% - TG Therapeutics, Inc.Oct 23, 2026TGTX ▲ +0.5% - TG Therapeutics, Inc.Oct 21, 2026
View full $TGTX filing history →💬 Comments
Loading comments…
Leave a comment